𝔖 Bobbio Scriptorium
✦   LIBER   ✦

[Cell Engineering] Cell Line Development Volume 6 || Engineering Mammalian Cells for Recombinant Monoclonal Antibody Production

✍ Scribed by Al-Rubeai, Mohamed


Book ID
111863384
Publisher
Springer Netherlands
Year
2009
Tongue
Dutch
Weight
646 KB
Edition
2009
Category
Article
ISBN
9048122457

No coin nor oath required. For personal study only.

✦ Synopsis


Mammalian cell lines command an effective monopoly for the production of therapeutic proteins that require post-translational modifications. This unique advantage outweighs the costs associated with mammalian cell culture, which are far grater in terms of development time and manufacturing when compared to microbial culture. The development of cell lines has undergone several advances over the years, essentially to meet the requirement to cut the time and costs associated with using such a complex hosts as production platforms. This book provides a comprehensive guide to the methodology involved in the development of cell lines and the cell engineering approach that can be employed to enhance productivity, improve cell function, glycosylation and secretion and control apoptosis. It presents an overall picture of the current topics central to expression engineering including such topics as epigenetics and the use of technologies to overcome positional dependent inactivation, the use of promoter and enhancer sequences for expression of various transgenes, site directed engineering of defined chromosomal sites, and examination of the role of eukaryotic nucleus as the controller of expression of genes that are introduced for production of a desired product. It includes a review of selection methods for high producers and an application developed by a major biopharmaceutical industry to expedite the cell line development process. The potential of cell engineering approch to enhance cell lines through the manipulation of single genes that play important roles in key metabolic and regulatory pathways is also explored throughout.


πŸ“œ SIMILAR VOLUMES


[Cell Engineering] Cell Line Development
✍ Al-Rubeai, Mohamed πŸ“‚ Article πŸ“… 2009 πŸ› Springer Netherlands 🌐 Dutch βš– 674 KB

Mammalian cell lines command an effective monopoly for the production of therapeutic proteins that require post-translational modifications. This unique advantage outweighs the costs associated with mammalian cell culture, which are far grater in terms of development time and manufacturing when comp

[Cell Engineering] Cell Line Development
✍ Al-Rubeai, Mohamed πŸ“‚ Article πŸ“… 2009 πŸ› Springer Netherlands 🌐 Dutch βš– 885 KB

Mammalian cell lines command an effective monopoly for the production of therapeutic proteins that require post-translational modifications. This unique advantage outweighs the costs associated with mammalian cell culture, which are far grater in terms of development time and manufacturing when comp

Engineering mammalian cell factories for
✍ Diane M. Dinnis; David C. James πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 233 KB

## Abstract In this review we consider how cell specific recombinant monoclonal antibody (Mab) production by engineered mammalian cells can be improved. Whilst it is generally recognized that Mab production is limited post‐transcriptionally at folding and assembly reactions, genetic engineering str

[Cell Engineering] Cell Line Development
✍ Al-Rubeai, Mohamed πŸ“‚ Article πŸ“… 2009 πŸ› Springer Netherlands 🌐 Dutch βš– 609 KB

Mammalian cell lines command an effective monopoly for the production of therapeutic proteins that require post-translational modifications. This unique advantage outweighs the costs associated with mammalian cell culture, which are far grater in terms of development time and manufacturing when comp

[Cell Engineering] Cell Line Development
✍ Al-Rubeai, Mohamed πŸ“‚ Article πŸ“… 2009 πŸ› Springer Netherlands 🌐 Dutch βš– 1015 KB

Mammalian cell lines command an effective monopoly for the production of therapeutic proteins that require post-translational modifications. This unique advantage outweighs the costs associated with mammalian cell culture, which are far grater in terms of development time and manufacturing when comp